GetTopicDetailResponse(id=ac0d114e358e, topicName=Tarlatamab, introduction=, content=小細胞肺癌 Tarlatamab, image=null, comments=0, allHits=851, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed May 22 20:14:17 CST 2024, time=2024-05-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=482049, tagList=[TagDto(tagId=482049, tagName=Tarlatamab)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2274776, encodeId=2b1422e47762c, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a> <a href='/topic/show?id=ac0d114e358e' target=_blank style='color:#2F92EE;'>#Tarlatamab#</a>, objectTitle=NEJM：Tarlatamab在鉑類化療后小細胞肺癌中的突破，改善生存與癥狀控制, objectType=article, longId=887985, objectId=94c288e98507, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241211/1733879465955_8538692.png, objectUrl=/article/show_article.do?id=94c288e98507, replyNumber=0, likeNumber=31, createdTime=2025-07-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=94c288e98507, moduleTitle=NEJM：Tarlatamab在鉑類化療后小細胞肺癌中的突破，改善生存與癥狀控制, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=94c288e98507)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2206081, encodeId=b72d2206081cd, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a> <a href='/topic/show?id=ac0d114e358e' target=_blank style='color:#2F92EE;'>#Tarlatamab#</a>, objectTitle=FDA 為無藥可用的小細胞肺癌批準新藥tarlatamab，部分患者生存期延長2倍！, objectType=article, longId=825495, objectId=c523825495e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716267297887_5579292.png, objectUrl=/article/show_article.do?id=c523825495e5, replyNumber=0, likeNumber=145, createdTime=2024-05-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c523825495e5, moduleTitle=FDA 為無藥可用的小細胞肺癌批準新藥tarlatamab，部分患者生存期延長2倍！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c523825495e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-05-22發(fā)表于上海
